Chronic Liver Disease

Gastroenterology
1
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Guerbet
GuerbetFrance - Villepinte
1 program
1
P03277 at 0.1 mmol/kgPhase 21 trial
Active Trials
NCT02973516Completed41Est. Apr 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GuerbetP03277 at 0.1 mmol/kg

Clinical Trials (1)

Total enrollment: 41 patients across 1 trials

NCT02973516GuerbetP03277 at 0.1 mmol/kg

Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis

Start: Dec 2016Est. completion: Apr 201941 patients
Phase 2Completed

Related Jobs in Gastroenterology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space